In addition, growing evidence suggests that the relevance of YKL-40 as a biomarker for AD is expanding [19], and CSF levels of YKL-40 may represent a novel and suitable biomarker with diagnostic utility for AD. The gene discussed is CHI3L1; the disease is Alzheimer disease.